[HTML] jci.org

[HTML][HTML] Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

S Körper, M Weiss, D Zickler… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND COVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing …
被引用次数：83 相关文章
[HTML] nih.gov

[HTML][HTML] Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

S Körper, M Weiss, D Zickler, T Wiesmann… - The Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND COVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing …

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

S Körper, M Weiss, D Zickler, T Wiesmann… - 2021 - pubmed.ncbi.nlm.nih.gov
BACKGROUNDCOVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing …

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19.

S Körper, M Weiss, D Zickler, T Wiesmann… - The Journal of …, 2021 - europepmc.org
BACKGROUND COVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing …

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19.

S Korper, M Weiss, D Zickler, T Wiesmann… - Journal of Clinical …, 2021 - go.gale.com
BACKGROUND. COVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing …

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

S Koerper, M Weiss, D Zickler… - Journal of …, 2021 - tobias-lib.ub.uni-tuebingen.de
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with
severe COVID-19 Results of the CAPSID randomized trial for high-dose convalescent plasma in …

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

S Koerper, M Weiss, D Zickler… - Journal of Clinical …, 2021 - ub01.uni-tuebingen.de
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with
severe COVID-19 Results of the CAPSID randomized trial for high-dose convalescent plasma in …

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

S Körper, M Weiss, D Zickler… - Journal of Clinical …, 2021 - search.proquest.com
BACKGROUND. COVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing …

[引用][C] Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

S Körper, M Weiss, D Zickler, T Wiesmann… - Journal of Clinical …, 2021 - oparu.uni-ulm.de
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with
severe COVID-19 Toggle navigation English Deutsch Deutsch English Deutsch Einloggen …

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

S Körper, M Weiss, D Zickler, T Wiesmann… - 2021 - pubmed.ncbi.nlm.nih.gov
BACKGROUNDCOVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing …